Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study
about
The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in JapaneseAllelic variants of the human putative peptide transporter involved in antigen processingA specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritisImmunogenetics of type 1 diabetes mellitusFamilial predisposition of type 1 diabetes mellitus in Japan, a country with low incidence. Japan Diabetes Society Data Committee for Childhood Diabetes.HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionAutoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction.Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.Cellular immune mechanisms in chronic autoimmune thrombocytopenic purpura (ATP).HLA-DR antigens and HLA-DQ beta chain polymorphism in susceptibility to rheumatoid arthritisMasked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of diseaseWorldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chainPossible deletion of a developmentally regulated heavy-chain variable region gene in autoimmune diseases.Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemiaMilk and diabetes.Screen and clean: a tool for identifying interactions in genome-wide association studiesShared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis.Genetic susceptibility to autoimmune thyroid disease: past, present, and futureMajor histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency.Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates.Thymus-specific deletion of insulin induces autoimmune diabetes.Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.Perspective on antigen processing and presentation.Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competitionCell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases.Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.RFLP analysis of HLA-DR beta and -DQ beta genes in the Korean patients with insulin-dependent diabetes mellitusPrediction and prevention of type 1 diabetes: update on success of prediction and struggles at preventionMolecular analysis of HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemia.Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses.Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell responseThe etiology of autoimmune thyroid disease: a story of genes and environmentGenetic determinants of type 1 diabetes across populations.Mutagenesis and expression of putative class II susceptibility genes: a "reverse immunogenetics" approach to analysis of HLA and disease.Genetic and epigenetic mechanisms in thyroid autoimmunity.On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants.
P2860
Q24299393-036EC607-E9B8-4675-A543-E199CC950C28Q24561683-43662814-59D0-43FA-A226-043F4D30FFC3Q24601796-EF3AF98B-98F7-498E-95F8-8DC55332954EQ28087365-5EC44A3B-8A9B-4B92-A9F3-C93CE2BC38D7Q30653733-7634D889-1AF0-4986-89F2-B6C8F5536E49Q30732418-2321B451-8BC1-4336-AAE2-08DA56266AC0Q32123429-040F5493-B52A-4D35-9E76-E13F00C4BBF9Q33220897-1B12B8DD-717A-4B0C-9316-711C66DC3A21Q33358576-0A3054BB-636C-4FDF-A8E4-92FCC17207F0Q33562773-18D8D816-4783-484F-A536-7B5DAF0B07DCQ33682376-27F354E1-2F58-468C-BC79-224F10B9E392Q33729769-5733E84B-2DC9-443D-8DCC-2E22881D0B96Q33810357-9C997FAD-33EB-48E6-81BB-E9A00BBBEC8BQ33838611-AD80892D-21C8-4DB1-8B47-356CF4397EDCQ33850554-A8999608-0063-4910-8E50-E873397DF097Q33887959-602BEF67-41F1-434C-9052-6BBC04786C85Q34042021-DF622BA8-2FCF-44E5-B1D1-F07A54465862Q34165404-7F71AEC8-E292-410C-BF5C-E245DCCE3CCCQ34171280-DAEE7AD4-A70F-4C3D-B8AF-78F4EDB6DDE5Q34220904-D21A4C5D-B330-4802-BC5B-C24F249E8ADEQ34314031-0C1214F1-7340-4E8C-96CF-8A130DEE36C6Q34610806-48F12A06-62A3-448B-BDD9-D018CEA14A32Q34612726-043C0940-92B1-4E41-87AA-336ACBF358F6Q34792432-CAF43D11-136F-46F3-BC63-2A12A6149254Q34982899-A6FC837F-32FA-439A-A151-C0E4B20042EAQ35242376-D4C1170A-0584-4E17-9B67-AE6D31264F94Q35605705-4C0D0B53-25CC-443E-8792-918778A44477Q35612872-C11472A2-273A-494B-9861-372A60B8AF06Q35865376-68C58056-BE28-465C-BDE9-1A0F1FA74809Q35948496-C2D396CE-207A-439D-ADDD-D8014DF4CECFQ36117948-2434472B-923E-44B3-8833-C77251A4D9F6Q36134654-74DB18AE-8AC5-4113-A2A1-F38C2ADC2186Q36206778-925AE7C2-B71E-4086-ABA5-7E9107D4219FQ36350204-2653B1C7-BBC7-455D-AFCE-22559D0A07B7Q36401332-8DAB5A82-22FC-444A-BCA8-12F6566FC0CFQ36579326-D4F6BD15-EE5D-4C10-9438-18C7C3B2874AQ36666082-D385F6F2-6CB3-4FF0-82BB-C9823858D417Q36681942-F33C38F5-C8D5-44FC-A030-127EC3E86B6DQ36694689-D50C13D7-C1FE-4C1A-9057-AF6B0E689169Q36718825-ECF92FB7-D1C8-41A4-B27E-3B9E9D69EE77
P2860
Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Aspartic acid at position 57 o ...... ype I diabetes: a family study
@ast
Aspartic acid at position 57 o ...... ype I diabetes: a family study
@en
type
label
Aspartic acid at position 57 o ...... ype I diabetes: a family study
@ast
Aspartic acid at position 57 o ...... ype I diabetes: a family study
@en
prefLabel
Aspartic acid at position 57 o ...... ype I diabetes: a family study
@ast
Aspartic acid at position 57 o ...... ype I diabetes: a family study
@en
P2093
P2860
P356
P1476
Aspartic acid at position 57 o ...... ype I diabetes: a family study
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.21.8111
P407
P577
1988-11-01T00:00:00Z